Multichamber Bioblock for Quasi In Vivo Cell Migration Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro testing methods, particularly 2D cell culture techniques, fail to accurately simulate in vivo conditions for assessing the biocompatibility of medical devices, leading to limitations in predicting cellular behavior and interactions, and lack reproducibility and standardization, making them inadequate for evaluating the safety and performance of implanted medical devices.
Innovation Solution
A specialized multichamber apparatus that recreates quasi in vivo conditions by simulating physiological environments, allowing real-time monitoring of cell migration and interaction with medical device surfaces, using a dynamic 3D cell culture system that can mimic human serum and various cell types, enabling the testing of medical devices in a controlled and reproducible manner.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If 2D in vitro cell culture techniques are used to assess medical device biocompatibility, then the testing process is simple and cost-effective, but the accuracy in predicting in vivo cellular behavior and interactions is insufficient
Solution Approach 1:
The patent transitions from traditional 2D cell culture to a 3D cell culture system where cells are grown on the surface of medical devices in a three-dimensional environment. This dimensional change allows cells to exhibit more natural behaviors including migration, proliferation, and interaction with the device surface, thereby improving the accuracy of predicting in vivo cellular responses while maintaining a manageable system complexity through standardized protocols and controlled environments.
2Reliability
If dynamic 3D cell culture system is implemented to simulate in vivo conditions, then the biocompatibility assessment accuracy improves, but the device complexity and operational difficulty increase
Solution Approach 1:
The patent implements a dynamic cell culture system that simulates physiological conditions through controlled fluid flow, nutrient delivery, and waste removal. The system allows for dynamic adjustment of flow rates, media composition, and environmental parameters to match in vivo conditions. This dynamic capability enhances the reliability and reproducibility of biocompatibility assessments by creating more physiologically relevant test environments, while standardized control protocols help manage operational complexity.
3Adaptability or versatility
If traditional 2D cell culture methods are used, then the testing protocol is standardized and easy to implement, but the ability to evaluate safety and performance of implanted devices is inadequate
Solution Approach 1:
The patent develops a universal 3D cell culture platform that can accommodate various types of implanted medical devices including implants, catheters, and surgical instruments. The system uses standardized cell culture protocols, media formulations, and environmental controls that can be applied across different device types and applications. This universality enhances the adaptability of the testing method to evaluate the safety and performance of diverse implanted devices while maintaining precision through consistent, reproducible testing conditions.
Data Source
AI summary
The invention discloses a quasi in-vivo testing method using a uniquely designed multichambered bioblock apparatus. Cells are placed inside a top chamber fitted with a pore size membrane that allows certain cells to migrate through the pores into a bottom chamber holding a substrate. The portion of cells migrating from the top chamber and interacting with the substrate surface in a real time physiological quasi in vivo environment can be used to determine both the migratory response of specific cell types to selected attractive surfaces and the effect of the migratory cells on the surface over selected times of exposure.